Vitrolife Ab · OMXSTO:VITR
Vitrolife Ab — Carnegie Healthcare Seminar 2023
16 slides from Vitrolife Ab's conference presentation, March 2023
Slide 1: Vitrolife Group - Excellence in Reproductive Health
Slide 2: Vitrolife AB (publ) - Carnegie Healthcare Seminar 2023
Vitrolife AB (publ) Patrik Tolf, CFO Carnegie Healthcare Seminar 2023 March 2023
Slide 3: More than 15% of all couples in fertile age suffer from fertility problems
More than 15% of all couples in fertile age suffer from fertility problems
Slide 4: Vitrolife Group - Excellence in reproductive health
Vitrolife Group - Excellence in reproductive health Global presence in 110 markets Employees Sales 2022 Vitrolife AB (publ) listed on ~1,100 3,234 MSEK NASDAQ Best-in-class IVF Leadership in Stockholm Large Cap medical devices reproductive portfolio genetic testing services Founded 1994 Founded 2011
Slide 5: Strong underlying growth with solid drivers in the IVF market
Strong underlaying growth with solid drivers in the IVF market • Delay in motherhood Demographic & social trends • Social acceptances and awareness of IVF • Lifestyle and social changes Top 5 markets worldwide North America • Improvement in IVF lab procedures (e.g. incubation system) Technical impro
Slide 6: Outcomes
Success rates “STEP BY STEP” Outcomes of ART Cycles Using Fresh Nondonor Eggs or Embryos The way an IVF clinic works is essential to a 160,000 successful treatment 140,000 120,000 IVF cycles started Egg retrievals 100,000 performed Embryo Outcomes 138,328 transfers 80,000 125,009 performed 107,795 6
Slide 7: Innovative embryo evaluation
Innovative embryo evaluation Two methods for embryo evaluation Combination improves successful treatment outcomes Algorithms based on the timing of specific events • Workflow optimization observed by time-lapse technology • Combined embryo evaluation • Ease of use and consistency PGT-A PGT-M Embrace
Slide 8: Supporting clinics in every step of the reproductive health journey
Supporting clinics in every step of the reproductive health journey Two of the strongest names within reproductive health into one platform to achieve successful treatment outcomes 8
Slide 9: Operating structure Vitrolife Group
Operating structure Vitrolife Group Executive Management and Group Functions Finance, Legal, IT, Strategy and HR & Sustainability Global Sales & Marketing Commercial excellence, Customer Services, Vitrolife Academy Media, cryo products, disposable devices and Incubation, time-lapse evaluation and la
Slide 10: Strong profitable growth
Strong profitable growth Fourth quarter Sales Organic growth* Adjusted gross margin 855 MSEK +11% 56.5% +66% in SEK In local currencies (56.9 % Pro forma) EBITDA EBITDA per share Operating cash flow 273 MSEK 2.02 SEK 166 MSEK Margin 31.9% (27.8% Pro forma) +196% (0 MSEK) Full year 2022 Sales Organic
Slide 11: Sales and growth per market region
Sales and growth per market region Total Q4 growth rate (local currencies) 81% 31% 32% 56% 48% Organic growth (local currencies) 8% 2% 21% 29% 11% Growth pro forma* (local currencies) 1% 6% 15% 24% 7% Sales (MSEK) 303 316 138 98 855 Share of Vitrolife 35% 37% 16% 12% Group’s sales 11 * Pro forma: Ex
Slide 12: Vitrolife Group vision, mission and strategy
Vitrolife Group Vision with a purpose —— Mission To fulfil the dream of To be the leading valued solution having a healthy baby. —_ provider in reproductive health and to support customers with successful _ treatment outcomes. Net debt / EBITDA 3 a Superior customer experience Sustainable structure
Slide 13: Our vision with a purpose: to fulfil the dream of having a healthy baby
Our vision with a purpose: to fulfil the dream of having a healthy baby 13
Slide 14: Thank you!
Thank you! Contact: Patrik Tolf, CFO, ptolf@vitrolife.com, +46 31 766 90 21 investors@vitrolife.com 14
Slide 15: Disclaimer
DISCLAIMER This presentation contains estimates and forward-looking statements, which reflect the Management’s current views with respect to the market, certain future events and financial performance. Although the statements are based upon estimates the Management believes to be reasonable, there i
Slide 16: Slide 16